While many clinical trials are being impacted by COVID-19 due to self-isolation, social distancing, travel limitations and site closures, fewer interruptions are being felt in the world of the virtual clinical trials and observational studies, many of which exist in the form of an online survey that takes 15 minutes or less to complete. We spoke with Dr. Matt Huentelman of the MindCrowd study and Dr. Rachel Nosheny of the Brain Health Registry (BHR) about how their online-based studies continue to collect important data related to Alzheimer’s and the brain during times of crisis.
